Treatment Guidelines Fraught With Financial Conflicts
The stated intent of treatment guidelines is to "guide" clinicians' treatment of patients with a series of recommendations based on evidence. But that intent may not be universally reflected in published guidelines and the disconnect is all about money. Money Talks Doctors with financial ties to
Childhood Diabetes: Kids Face Lifetime of Illness
Briana Johnson was 8 years old when her doctor tested her for diabetes . "My camp counselor said it would be a good idea, since I was always using the bathroom, always thirsty," said Johnson, recalling the last summer she could eat popsicles or drink juice just to keep cool. With a simple blood
Diabetes in Kids: Combo Treatment Tops
A combination of the diabetes staple drug metformin plus Avandia is best at controlling blood sugar in children and adolescents with type 2 diabetes , researchers found. The combination was superior to monotherapy with metformin, even though the use of Avandia has fallen off in the U.S. and Europe
FDA Warns of Bladder Cancer Risk With Actos
Patients taking the diabetes drug Actos for more than a year may have an increased risk of bladder cancer , according to an FDA interim review of an ongoing epidemiological study. The warning comes just days after two European countries banned use of the drug. The European Medicines Agency (EMA)
U.S. Delegation Walks Out on Ahmadinejad
Iran's president offered his version of 9/11 in controversial speech to the U.N.
Crusading Doctor Gets FDA to Restrict Deadly Drug
As other drugs' safety are questioned, FDA finally pulls drug after eight years.
Avandia Stays, but Only for Some Diabetes Patients
The U.S. Food and Drug Administration today announced it will significantly restrict the use of the diabetes drug rosiglitizone -- popularly known as Avandia -- after subsequent reviews of the drug suggest a higher risk of heart attack. Meanwhile, the European Medicines Agency, the FDA's European
Investigation Raises More Questions About Avandia
U.K. Advisory Commission Said the Diabetes Drug Should Not Be on the Market